According to the latest report by IMARC Group, titled “Endocrine Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global endocrine testing market size reached US$ 10 Billion in 2020. Endocrine testing assists in detecting a hormonal imbalance in the body, which may lead to the development of different chronic conditions. It is advised by doctors to measure hormonal levels and diagnose hormonal-related disorders. These disorders are generally tested via venous sampling, fine-needle aspiration (FNA), radioactive iodine scan (RAI), positron emission test (PET), magnetic resonance imaging (MRI), ultrasound, and computerized tomography (CT). The demand for endocrine testing is escalating around the world on account of the growing prevalence of endocrine-related disorders like gigantism, hypothyroidism, hyperthyroidism, Cushing’s disease, and adrenal insufficiency.

Get a sample copy of this Report: https://www.imarcgroup.com/endocrine-testing-market/requestsample

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Global Endocrine Testing Market Trends:

The rising health consciousness among individuals about the benefits of timely testing represents one of the key factors strengthening the growth of the market. It aids in minimizing the risk of developing complications or aggravating the disorder. Apart from this, the growing geriatric population is also driving the market. Moreover, with the outbreak of the coronavirus disease (COVID-19) pandemic, endocrine testing is being widely used to diagnose hyperglycemia in patients. The introduction of innovative test kits equipped with biosensors that provide cost-effective and user-friendly home-based diagnosis is also impelling the market growth. Furthermore, laboratories, diagnostic centers, and healthcare centers are relying on technologically advanced liquid chromatography with mass spectrometry (LC-MS) techniques to offer precise and accurate results. This, in confluence with improvements in the healthcare infrastructure, is propelling the market growth. Looking forward, the market is projected to expand at a CAGR of 8.7% during the forecast period (2021-2026).

View Full Report with TOC & List of Figure: https://bit.ly/3ppMEg0

Competitive Landscape with Key players:

The competitive landscape of the industry has also been examined with some of the key players.

• Abbott Laboratories
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• BioMerieux SA
• DiaSorin S.p.A.
• Hoffmann-La Roche AG (Roche Holding AG)
• Laboratory Corporation of America Holdings
• Quest Diagnostics Incorporated
• Thermo Fisher Scientific Inc

Global Endocrine Testing Market Segmentation:

Our report has categorized the market based on region, test type, technology and end-use.

By Test Type:

• Thyroid Test
• Insulin Test
• Human Chorionic Gonadotropin Test
• Prolactin Test
• Luteinizing Hormone Test
• Progesterone Test
• Others

By Technology:

• Immunoassay
• Tandem Mass Spectroscopy
• Sensor Technology
• LC-MS
• Others

By End Use:

• Hospitals
• Ambulatory Care Centers
• Clinical Laboratories
• Others

By Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

• Market Performance
• Market Outlook
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800